Citation Impact
Citing Papers
Complement drives Th17 cell differentiation and triggers autoimmune arthritis
2010 StandoutNobel
Vascular Klotho Deficiency Potentiates the Development of Human Artery Calcification and Mediates Resistance to Fibroblast Growth Factor 23
2012 Standout
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
C3 Promotes Expansion of CD8+ and CD4+ T Cells in a Listeria monocytogenes Infection
2009
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
2009 Standout
Graft microvascular disease in solid organ transplantation
2014 StandoutNobel
Inflammation and Alzheimer's disease
2000 Standout
Proceedings: Pathogenesis and Treatment of Renal Osteodystrophy
2003
Complement and its role in innate and adaptive immune responses
2009 Standout
Vascular Calcification Mechanisms
2004 Standout
High Prevalence of Vitamin D Inadequacy and Implications for Health
2006 Standout
The spectrum of neuromyelitis optica
2007 Standout
Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats
2006
Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats
2003
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
2008 Standout
Overview of general physiologic features and functions of vitamin D
2004 Standout
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
2011 Standout
Analytical measurement and clinical relevance of vitamin D3 C3-epimer
2012
Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy
1992
The N-formyl peptide receptor: A model for the study of chemoattractant receptor structure and function
1997
The N-formyl peptide receptors and the anaphylatoxin C5a receptors: An overview
2007
Function, structure and therapeutic potential of complement C5a receptors
2007
Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients
2010
Vitamin D Metabolism, Mechanism of Action, and Clinical Applications
2014 Standout
Vitamin D Deficiency
2007 Standout
Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management
2000
Induction of anaphylatoxin C5a receptors in rat hepatocytes by lipopolysaccharide in vivo: Mediation by interleukin-6 from Kupffer cells
2002
Phagocyte Chemoattractant Receptors
1997
The Effects of Sevelamer Hydrochloride and Calcium Carbonate on Kidney Calcification in Uremic Rats
2002
Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis
2000 Standout
Expression of the anaphylatoxin C5a receptor in non-myeloid cells
1999
Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D.
1995
Bone histomorphometry in hypoparathyroid patients treated with vitamin D
1996
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia
2003
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease
2010 Standout
Role of Calcium-Phosphate Product and Bone-Associated Proteins on Vascular Calcification in Renal Failure
2001
Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells
1998
Intermittent calcitriol therapy in secondary hyperparathyroidism: A comparison between oral and intraperitoneal administration
1998
N-Formyl Peptide Receptors Internalize but Do Not Recycle in the Absence of Arrestins
2003 StandoutNobel
Aptamers as therapeutics
2010 Standout
Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease
2004 Standout
Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality
2003 Standout
Complement factors and their receptors
1997
Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism
2003
Structure-Function Relationships in the Vitamin D Endocrine System*
1995
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
Enhanced expression of complement C5a receptor mRNA in human diseased kidney assessed by in situ hybridization
2001
Evolution of anaphylatoxins, their diversity and novel roles in innate immunity: Insights from the study of fish complement
2005
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
2011 Standout
CLINICAL COUNTERPOINT: Vitamin D: New Actions, New Analogs, New Therapeutic Potential*
1992
Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients
2009
A Membrane-proximal Basic Domain and Cysteine Cluster in the C-terminal Tail of CCR5 Constitute a Bipartite Motif Critical for Cell Surface Expression
2001 StandoutNobel
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
2002 Standout
Vitamin D
2005
FGF23 Fails to Inhibit Uremic Parathyroid Glands
2010
The Classical Complement Cascade Mediates CNS Synapse Elimination
2007 Standout
Processes in atherogenesis: complement activation
1997
Phosphate Restriction in Diet Therapy
2007
Vitamin D-dependent seasonal variation of PTH in growing male adolescents
1995
Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
2006 Standout
Hyperphosphataemia in Renal Failure
2003
Role of C5a???C5aR Interaction in Sepsis
2003
Expression of complement in the brain: role in health and disease
1996
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism
2004 Standout
Derivation of RNA aptamer inhibitors of human complement C5
1999
Pharmacological and clinical properties of calcimimetics: Calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism
2005
Pathogenesis of vascular calcification in chronic kidney disease
2005
Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure
1997
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
Are we mismanaging calcium and phosphate metabolism in renal failure?
1997
FGF-23 and secondary hyperparathyroidism in chronic kidney disease
2013
Structure, function and cellular expression of complement anaphylatoxin receptors
1995
25-Hydroxyvitamin D3 suppresses PTH synthesis and secretion by bovine parathyroid cells
2006
Intravenous Paricalcitol for Treatment of Secondary Hyperparathyroidism in Children on Hemodialysis
2007
Chronic Kidney Disease
2016 Standout
Metabolism of 1α,25-dihydroxyvitamin D3 and its C-3 epimer 1α,25-dihydroxy-3-epi-vitamin D3 in neonatal human keratinocytes
2001
Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia
1995
Long-term effects of sevelamer hydrochloride on the calcium × phosphate product and lipid profile of haemodialysis patients*
1999
Lanthanum Carbonate Reduces Phosphorus Burden in Patients with CKD Stages 3 and 4
2008
The dark side of C5a in sepsis
2004
The dawning era of polymer therapeutics
2003 Standout
Vitamin D deficiency: a worldwide problem with health consequences
2008 Standout
The C5a chemoattractant receptor mediates mucosal defence to infection
1996 Nature
Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
2011 Standout
Relative in Vitro Efficacy of the Phosphate Binders Lanthanum Carbonate and Sevelamer Hydrochloride
2007 StandoutNobel
An Official American Thoracic Society Workshop Report: Features and Measurements of Experimental Acute Lung Injury in Animals
2011 Standout
Human T Cells Express the C5a Receptor and Are Chemoattracted to C5a
1999
C5a receptor and thymocyte apoptosis in sepsis
2002
Cell Biology of the Glomerular Podocyte
2003 Standout
Sevelamer with and without calcium and vitamin D: Observations from a long-term open-label clinical trial
2000
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
ROLE OF C5A IN INFLAMMATORY RESPONSES
2005
C-3 Epimers Can Account for a Significant Proportion of Total Circulating 25-Hydroxyvitamin D in Infants, Complicating Accurate Measurement and Interpretation of Vitamin D Status
2006
Regulation of C-Terminal and Intact FGF-23 by Dietary Phosphate in Men and Women
2006
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001 Standout
Inhibition of a Membrane Complement Regulatory Protein by a Monoclonal Antibody Induces Acute Lethal Shock in Rats Primed with Lipopolysaccharide
1999
The pathogenesis of parathyroid gland hyperplasia in chronic renal failure
1995
The Receptor for Complement Anaphylatoxin C3a Is Expressed by Myeloid Cells and Nonmyeloid Cells in Inflamed Human Central Nervous System: Analysis in Multiple Sclerosis and Bacterial Meningitis
1998
C-3 Epimerization of Vitamin D3 Metabolites and Further Metabolism of C-3 Epimers
2004
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism
2004 Standout
PLEIOTROPIC EFFECTS OF STATINS
2004 Standout
Synthesis of Sulfotyrosine‐Containing Peptides by Incorporating Fluorosulfated Tyrosine Using an Fmoc‐Based Solid‐Phase Strategy
2015 StandoutNobel
Phosphate Regulation of Vascular Smooth Muscle Cell Calcification
2000 Standout
Inactivation of C5a Anaphylatoxin by a Peptide That Is Complementary to a Region of C5a
2004 StandoutNobel
Vitamin D
1999
Meta-analysis of the effect of sevelamer on phosphorus, calcium, PTH, and serum lipids in dialysis patients
2003
Membrane Attack Complex Contributes to Destruction of Vascular Integrity in Acute Lung Allograft Rejection
2002
Effect of Phosphate on Parathyroid Hormone Secretion In Vivo
1999
Vascular Calcification
2006 Standout
Lung Infections Associated with Cystic Fibrosis
2002 Standout
Bone metabolism and disease in chronic kidney disease
2003
Cinacalcet HCl: a calcimimetic agent for the management of primary and secondary hyperparathyroidism
2003
RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone
1999
Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system.
1997
Physiology of Microglia
2011 Standout
Works of Amberly Brown being referenced
Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro.
1996
The Role of Phosphorus in the Development of Secondary Hyperparathyroidism and Parathyroid Cell Proliferation in Chronic Renal Failure
1999
Retinoic acid suppresses parathyroid hormone (PTH) secretion and PreproPTH mRNA levels in bovine parathyroid cell culture.
1994
Pacritinib to inhibit JAK/STAT signaling in refractory metastatic colon and rectal cancer
2017
1?,25-Dihydroxy-3-Epi-vitamin D3, a natural metabolite of 1?,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion
1999
Effects of calcitriol and non-calcemic vitamin D analogs on secondary hyperparathyroidism.
1992
Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung.
1995
1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion.
1999
The parathyroid-calcitriol axis in health and chronic renal failure.
1990